Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ...
Dr Shuvendu Majumder mukhopadhyay.dinabandhu@gmail.com The maiden volume “Startups for Viksit Bharat-2047” represents a ...
New office will integrate market analysis, strategy formulation, and opportunity creation to boost NX’s regional presence ...
Gelatine Sculpt is positioned within the evolving landscape of weight management solutions as a structured, liquid-based ...
Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development ...
Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ: WNW) announced today that the Company is introducing a strategic artificial intelligence ("AI") insights initiative as part of its ...
As awareness of ultra‑processed foods grows faster than consumers’ ability to identify them, startups face mounting pressure ...
I could spend a lot of this column musing about the absolute whiplash gripping the American and global commentariat surrounding the announcement of a ceasefire in the Iran War Tuesday evening. Instead ...
As awareness around “Jello weight loss” methodologies continues to expand, structured formulations like Gelatide are being ...
The abrupt removal of Army Chief of Staff General Randy George by Secretary of Defense Pete Hegseth on April 2, 2026, via ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results